Latest filing published 24 Feb 2026 for ImmunityBio, Inc., €573k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Richard Adcock: trading record in brief
Richard Adcock (chief executive) discloses dealings in ImmunityBio, Inc. to SEC (Form 4). Between 5 February 2021 and 22 February 2026, the trades on record add up to 26 filings.
On the market, this insider has only ever bought: 2 purchases, €15k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 12 share grants and 12 option exercises.
Most recently, on 24 February 2026, the filings show a share grant worth €573k in ImmunityBio, Inc. The last purchase on record was published on 8 October 2021, which is 1,858 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Richard Adcock
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 77,560 shares@ US$8.7049.5% of flowCommon StockSEC:0001830328-26-000005:1
- 152,439 shares0Common StockSEC:0001830328-26-000005:0
- 274,122 shares0Common StockSEC:0001830328-26-000003:0
- 34,483 shares0Common StockSEC:0001830328-26-000001:0
- 78,167 shares@ US$3.4222.0% of flowCommon StockSEC:0001326110-25-000021:1
- 152,439 shares0Common StockSEC:0001326110-25-000021:0
- 34,483 shares0Common StockSEC:0001326110-25-000004:0
- 83,334 shares0Common StockSEC:0001326110-24-000018:0
- 43,165 shares@ US$4.0414.0% of flowCommon StockSEC:0001326110-24-000018:1
- 34,483 shares0Common StockSEC:0001326110-24-000007:0
- 42,192 shares@ US$4.3314.5% of flowCommon StockSEC:0001326110-23-000010:1
- 83,333 shares0Common StockSEC:0001326110-23-000010:0
- 8,620 shares0Common StockSEC:0001326110-23-000004:0
- 83,333 shares0Common StockSEC:0001326110-22-000006:0
- 7 shares@ US$9.000.0% of flowCommon StockSEC:0001326110-21-000005:0Canonical exit: 6 Jan 2022 (T+90)
- 8,620 shares0Common StockSEC:0001209191-21-055785:0
16 of 16 declarations
